Your browser doesn't support javascript.
loading
Nilotinib as Coadjuvant Treatment with Doxorubicin in Patients with Sarcomas: A Phase I Trial of the Spanish Group for Research on Sarcoma.
Alemany, Regina; Moura, David S; Redondo, Andres; Martinez-Trufero, Javier; Calabuig, Silvia; Saus, Carlos; Obrador-Hevia, Antonia; Ramos, Rafael; Villar, Victor H; Valverde, Claudia; Vaz, Maria Angeles; Medina, Javier; Felipe-Abrio, Irene; Hindi, Nadia; Taron, Miguel; Martin-Broto, Javier.
Affiliation
  • Alemany R; Department of Biology, Balearic Islands University, Palma de Mallorca, Spain.
  • Moura DS; Group of Advanced Therapies and Biomarkers in Clinical Oncology, Institut d'Investigació Sanitària de les Illes Balears (IdISBa-IUNICS), Palma de Mallorca, Spain.
  • Redondo A; Instituto de Biomedicina de Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), Lab.215, Sevilla, Spain.
  • Martinez-Trufero J; Medical Oncology Department, University Hospital La Paz, Madrid, Spain.
  • Calabuig S; Medical Oncology Department, University Hospital Miguel Servet, Zaragoza, Spain.
  • Saus C; Molecular Oncology Laboratory, Fundación Investigación, Hospital General Universitario de Valencia, Valencia, (Spain). Centro de Investigación Biomédica en Red de Cáncer (CIBEROnc), Madrid, Spain. Department of Pathology, Universitat de València, Valencia, Spain.
  • Obrador-Hevia A; Pathology Department, University Hospital Son Espases, Palma de Mallorca, Spain.
  • Ramos R; Group of Advanced Therapies and Biomarkers in Clinical Oncology, Institut d'Investigació Sanitària de les Illes Balears (IdISBa-IUNICS), Palma de Mallorca, Spain.
  • Villar VH; Sequencing Unit, University Hospital Son Espases, Palma de Mallorca, Spain.
  • Valverde C; Pathology Department, University Hospital Son Espases, Palma de Mallorca, Spain.
  • Vaz MA; Department of Biology, Balearic Islands University, Palma de Mallorca, Spain.
  • Medina J; Medical Oncology Department, University Hospital Vall d'Hebron, Barcelona, Spain.
  • Felipe-Abrio I; Medical Oncology Department, University Hospital Ramon y Cajal, Madrid, Spain.
  • Hindi N; Medical Oncology Department, Hospital Virgen de la Salud, Toledo, Spain.
  • Taron M; Instituto de Biomedicina de Sevilla (IBIS, HUVR, CSIC, Universidad de Sevilla), Lab.215, Sevilla, Spain.
  • Martin-Broto J; Epithelial Carcinogenesis Group, Spanish National Cancer Research Centre-CNIO, Madrid, Spain.
Clin Cancer Res ; 24(21): 5239-5249, 2018 11 01.
Article in En | MEDLINE | ID: mdl-30037815

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma / Antineoplastic Combined Chemotherapy Protocols Type of study: Diagnostic_studies Limits: Animals / Female / Humans / Male Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2018 Document type: Article Affiliation country: Spain Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma / Antineoplastic Combined Chemotherapy Protocols Type of study: Diagnostic_studies Limits: Animals / Female / Humans / Male Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2018 Document type: Article Affiliation country: Spain Country of publication: United States